Results 261 to 270 of about 10,318 (317)

Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. [PDF]

Cardiovasc Diabetol
Chaiyakunapruk N, Tan X, Liang Y, Guevarra M, Xie L, Cheng AYY.   +5 more
europepmc   +1 more source

Target Trial Emulation: A Rigorous Framework for Causal Inference in Real-World Data Studies (Motivated by the OneFlorida+ Study on GLP-1RA and SGLT2i Use and Dementia Risk in Type 2 Diabetes by Tang et al.)

Ricardo Pietrobon, Aline Machiavelli, Luiza Paulsen Rodrigues, Amit Agrey, Lizzy Nkeangnyi, Giselle Zechia, Victor Galvão, Lucas Teixeira   +7 more
openalex   +2 more sources

Secondary stroke prevention beyond antiplatelets: The role of colchicine and GLP-1RA - an ounce of prevention is worth a pound of cure. [PDF]

Ther Adv Neurol Disord
Mijajlović MD, Bornstein NM, Aleksić V.   +2 more
europepmc   +1 more source

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial. [PDF]

Am J Prev Cardiol
Nelson AJ, Kaltenbach LA, Al-Khalidi HR, Leyva M, Webb L, McGuire DK, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Pandey A, Gaynor T, Pak J, Washington A, Senyucel C, Lopes RD, Green JB, Granger CB, Pagidipati NJ.   +21 more
europepmc   +1 more source

GLP-1RA-induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis. [PDF]

Pharmacotherapy
Hooper L, Liu S, Pai MP.
europepmc   +1 more source

Moving Mountains of A1c and Weight in T2D with oral GLP-1RA – More is More

Norlela Sukor
openalex   +2 more sources

Combined Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) and Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Therapy to Restore Fertility in Patients With Obesity, Polycystic Ovary Syndrome, and Incident Type 2 Diabetes. [PDF]

Cureus
Banerjee M, Dasgupta S.
europepmc   +1 more source

Relative contribution of different effects to overall improvement in disability-adjusted life years (DALYs) with GLP-1RA and SGLT2-i therapy.

Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC (21144089)
openalex   +1 more source

The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes. [PDF]

Metabolites
Sinclair A, Siqueira I, Abdelhafiz A.
europepmc   +1 more source

GLP-1RA improves diabetic renal injury by alleviating glomerular endothelial cells pyrotosis via RXRα/circ8411/miR-23a-5p/ABCA1 pathway

Weixi Wu, Yao Wang, Xian Shao, Shuai Huang, Jian Wang, Saijun Zhou, Hongyan Liu, Yao Lin, Pei Yu   +8 more
openalex   +1 more source